Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Personalized Music, Dreaming During Propofol Sedation

12 août 2026 mis à jour par: Cheol Lee,MD,PhD,, Wonkwang University Hospital

Personalized Music Increases Dreaming During Propofol Sedation: A Randomized Trial Comparing Preferred Music, Matched Non-preferred Music, and Silence

This randomized clinical trial will evaluate whether music delivered through closed-back headphones during intravenous propofol sedation affects dreaming and the overall sedation experience. Adults scheduled for elective procedures under spinal anesthesia or peripheral nerve block with propofol sedation will be randomly assigned to one of three groups: patient-selected preferred music, matched non-preferred music, or silence with identical headphones.

The main purpose of the study is to determine whether listening to music increases the occurrence of dream recall compared with silence, and whether personally preferred music makes recalled dreams more pleasant than matched non-preferred music. Dream recall and dream pleasantness will be assessed after recovery using a standardized interview. The study will also evaluate dream content, patient satisfaction, sedative and opioid requirements, hemodynamic variability, postoperative pain, nausea and vomiting, recovery time, and adverse events.

This study is intended to determine whether a simple, low-cost headphone-based music intervention can improve patient-centered quality of propofol sedation without compromising safety.

Aperçu de l'étude

Description détaillée

Dreaming during intravenous propofol sedation is common and may influence how patients remember their perioperative experience. External auditory stimulation can sometimes be processed during sedation and may be incorporated into dream content. Music is a practical auditory intervention because it can be delivered through headphones without interfering with anesthetic care or the surgical workflow. However, it remains unclear whether music itself increases dream recall during propofol sedation, and whether patient-selected music provides additional benefit beyond exposure to music with similar acoustic features.

The modified Brice interview will be administered as soon as the participant has adequately recovered consciousness and is able to communicate in the PACU. Because dream recall may fade over time, the interview will be conducted at the earliest feasible time point after recovery of consciousness and no later than 60 minutes after PACU arrival.

This single-center, parallel-group, three-arm randomized controlled trial will compare three auditory conditions during propofol sedation: preferred music, matched non-preferred music, and silence. Participants assigned to the preferred music group will listen to one personally selected track through closed-back headphones. Participants assigned to the matched non-preferred music group will listen to a pleasant but non-selected track matched to the preferred music by genre family, tempo, and loudness. Participants assigned to the silence control group will wear identical closed-back headphones without music playback. In all groups, the assigned auditory condition will begin shortly before sedative administration and continue until the end of the sedation period.

The study population will consist of adults undergoing elective procedures under spinal anesthesia or peripheral nerve block with intravenous propofol sedation. Propofol sedation will be administered according to a standardized protocol and titrated to a predefined sedation depth using clinical sedation scales, with processed electroencephalographic monitoring recorded when available. Standard intraoperative monitoring will be performed according to institutional anesthetic practice.

The study has two main comparisons. First, the two music groups will be pooled and compared with the silence group to assess whether auditory stimulation increases dream recall. Second, the preferred music group will be compared with the matched non-preferred music group to assess whether personalization improves dream pleasantness among participants who recall dreams. Dream recall and dream pleasantness will be assessed in the post-anesthesia care unit using a standardized, neutral interview after participants meet predefined recovery-readiness criteria.

Additional assessments will include coded dream content, auditory salience, emotional valence, vividness, perceived control within the dream, patient satisfaction, propofol dose, opioid use, hemodynamic variability, recovery time, postoperative pain, postoperative nausea and vomiting, and adverse events. Dream narratives will be coded by blinded assessors using a prespecified codebook. Outcome assessors, content coders, and statisticians will remain blinded to group allocation whenever feasible.

The overall aim is to determine whether structured headphone-based music, particularly patient-preferred music, can improve the subjective quality of propofol sedation while maintaining clinical safety. The findings may inform whether routine music delivery and optional music preference capture should be incorporated into perioperative sedation workflows.

Type d'étude

Interventionnel

Inscription (Réel)

300

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Jeollabukdo
      • Iksan, Jeollabukdo, Corée du Sud
        • Wonkwag UH

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Adults aged 19 years or older.
  • Scheduled to undergo an elective procedure under spinal anesthesia or peripheral nerve block with intravenous propofol sedation.
  • American Society of Anesthesiologists physical status I to III.
  • Able to provide written informed consent.
  • Able to wear closed-back headphones during the study period.
  • Able to complete postoperative interviews and study questionnaires.

Exclusion Criteria:

  • Planned general anesthesia.
  • Severe hearing impairment that would interfere with the auditory intervention.
  • Major psychiatric instability or condition that may interfere with study participation or dream assessment.
  • Expected significant intraoperative bleeding.
  • Inability to complete the required postoperative interviews or questionnaires.
  • Contraindication to propofol or other study sedative agents.
  • Refusal or withdrawal of informed consent.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Preferred Music
Participants assigned to this arm will listen to one personally selected preferred music track through identical closed-back headphones during intravenous propofol sedation. Playback will begin 1-2 minutes before sedative administration and continue until the end of the sedation period. The track may include either lyrical or instrumental music according to participant preference.
A personally selected music track will be played through closed-back headphones during intravenous propofol sedation.
Autres noms:
  • Patient-selected music Personalized music
Comparateur actif: Matched Non-preferred Music
Participants assigned to this arm will listen to one pleasant but non-selected music track through identical closed-back headphones during intravenous propofol sedation. The track will be matched to the participant's preferred music by genre family, tempo, and loudness, but it will not be personally selected by the participant. Playback will begin 1-2 minutes before sedative administration and continue until the end of the sedation period.
A pleasant, non-selected music track matched by genre, tempo, and loudness will be played through closed-back headphones during intravenous propofol sedation.
Autres noms:
  • Matched music Non-selected music
Comparateur factice: Silence Control
Participants assigned to this arm will wear identical closed-back headphones during intravenous propofol sedation, but no audio will be played. The headphones will be applied for the same period as in the music arms, beginning 1-2 minutes before sedative administration and continuing until the end of the sedation period. This arm controls for headphone use, attention, and expectancy without auditory stimulation.
Participants will wear identical closed-back headphones during intravenous propofol sedation, but no audio will be played.
Autres noms:
  • Headphones without playback No-audio control

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Dream Incidence
Délai: At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Occurrence of dream recall after intravenous propofol sedation, assessed using a neutral modified Brice interview. Participants will be classified as having dream recall or no dream recall.
At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Dream Pleasantness
Délai: At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Pleasantness of recalled dreams among participants who report dream recall, assessed using a 0 to 10 numeric rating scale, where higher scores indicate more pleasant dreams.
At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Within 60 minutes after arrival in the post-anesthesia care unit
Délai: At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Degree of auditory salience in recalled dream content, assessed by blinded content coders using a 0 to 3 scale, where higher scores indicate greater auditory salience.
At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Affect Valence of Dream Content
Délai: At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Emotional valence of recalled dream content, assessed by blinded content coders using a scale from -2 to +2, where higher scores indicate more positive affect.
At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Dream Vividness
Délai: At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Vividness of recalled dreams, assessed using a 0 to 10 numeric rating scale, where higher scores indicate more vivid dream experiences.
At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Sense of Control in Dream
Délai: At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Participant-reported sense of control or agency within the recalled dream, assessed using a 0 to 10 numeric rating scale, where higher scores indicate greater perceived control.
At first adequate recovery of consciousness in the post-anesthesia care unit, up to 60 minutes after PACU arrival
Patient Satisfaction With Sedation Experience
Délai: Assessed once at discharge from the post-anesthesia care unit, approximately within 2 hours after completion of sedation
Participant satisfaction with the sedation experience will be assessed using a 5-point Patient Satisfaction Scale, ranging from 1 to 5. A score of 1 indicates very dissatisfied, and a score of 5 indicates very satisfied. Higher scores indicate greater satisfaction with the sedation experience.
Assessed once at discharge from the post-anesthesia care unit, approximately within 2 hours after completion of sedation

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Cheol Lee, M.D.,Ph.D, Wonkwang University Hosptial

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

24 juin 2026

Achèvement primaire (Réel)

12 juillet 2026

Achèvement de l'étude (Réel)

9 août 2026

Dates d'inscription aux études

Première soumission

31 mai 2026

Première soumission répondant aux critères de contrôle qualité

5 juin 2026

Première publication (Réel)

10 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

14 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • Wonkwang UH26

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner